| For: | Kasper HU, Drebber U, Stippel DL, Dienes HP, Gillessen A. Liver tumor infiltrating lymphocytes: Comparison of hepatocellular and cholangiolar carcinoma. World J Gastroenterol 2009; 15(40): 5053-5057 [PMID: 19859998 DOI: 10.3748/wjg.15.5053] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i40/5053.htm |
| Number | Citing Articles |
| 1 |
Cun-Li Guo, Hai-Chao Yang, Xiu-Hua Yang, Wen Cheng, Tian-Xiu Dong, Wen-Jing Zhu, Zheng Xu, Liang Zhao. Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2012; 13(11) doi: 10.7314/APJCP.2012.13.11.5909
|
| 2 |
Takayuki Takeichi, Paulius Mocevicius, Olegas Deduchovas, Olga Salnikova, Edward Castro‐Santa, Markus W. Büchler, Jan Schmidt, Eduard Ryschich. αLβ2 Integrin is indispensable for CD8+ T‐cell recruitment in experimental pancreatic and hepatocellular cancer. International Journal of Cancer 2012; 130(9) doi: 10.1002/ijc.26223
|
| 3 |
Shuting Han, Suat Ying Lee, Who-Whong Wang, Yu Bin Tan, Rachel Hui Zhen Sim, Rachael Cheong, Cherlyn Tan, Richard Hopkins, John Connolly, Wai Ho Shuen, Han Chong Toh. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers 2020; 12(11) doi: 10.3390/cancers12113404
|
| 4 |
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alejandro Forner, Juan W Valle, Eugenio Gaudio, Domenico Alvaro, Jesus M Banales, Guido Carpino. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022; 71(8) doi: 10.1136/gutjnl-2022-327099
|
| 5 |
Xianwen Ren, Zemin Zhang. Advances in Immunology in China - Part A. Advances in Immunology 2019; 144 doi: 10.1016/bs.ai.2019.08.004
|
| 6 |
Hongru Cao, Ping Huang, Jiawei Qiu, Xiaohui Gong, Hongfei Cao. Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model. Heliyon 2024; 10(3) doi: 10.1016/j.heliyon.2024.e24861
|
| 7 |
. 2024; doi: 10.70675/e829496azb11ez4563zb5c8z74b7e8e8ff61
|
| 8 |
Joachim C. Mertens, Ralph Fritsch. Immune Strategies for Gastrointestinal Cancer. Cancer Immunotherapy 2023; 2 doi: 10.1007/13905_2022_35
|
| 9 |
Qing Pang, Lei Zhou, Kai Qu, Rui-Xia Cui, Hao Jin, Hui-Chun Liu. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study. European Journal of Gastroenterology & Hepatology 2018; 30(1) doi: 10.1097/MEG.0000000000001021
|
| 10 |
Jia Liu, Tongyuan Zhang, Yang Gao, Dong Ji, Lijian Chen. Causal role of immune cells in primary liver cancer: a mendelian randomization study. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14327-1
|
| 11 |
Giorgia Alvisi, Alberto Termanini, Cristiana Soldani, Federica Portale, Roberta Carriero, Karolina Pilipow, Guido Costa, Michela Polidoro, Barbara Franceschini, Ines Malenica, Simone Puccio, Veronica Lise, Giovanni Galletti, Veronica Zanon, Federico Simone Colombo, Gabriele De Simone, Michele Tufano, Alessio Aghemo, Luca Di Tommaso, Clelia Peano, Javier Cibella, Matteo Iannacone, Rahul Roychoudhuri, Teresa Manzo, Matteo Donadon, Guido Torzilli, Paolo Kunderfranco, Diletta Di Mitri, Enrico Lugli, Ana Lleo. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. Journal of Hepatology 2022; 77(5) doi: 10.1016/j.jhep.2022.05.043
|
| 12 |
Jennifer Lohr, Thomas Ratliff, Andrea Huppertz, Yingzi Ge, Christine Dictus, Rezvan Ahmadi, Stefan Grau, Nobuyoshi Hiraoka, Volker Eckstein, Rupert C. Ecker, Thomas Korff, Andreas von Deimling, Andreas Unterberg, Philipp Beckhove, Christel Herold-Mende. Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β. Clinical Cancer Research 2011; 17(13) doi: 10.1158/1078-0432.CCR-10-2557
|
| 13 |
Atsushi Kawabata, Naomi Ohta, Garret Seiler, Marla M. Pyle, Susumu Ishiguro, Yong Qing Zhang, Kevin G. Becker, Deryl Troyer, Masaaki Tamura. Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses. Cytotherapy 2013; 15(5) doi: 10.1016/j.jcyt.2013.01.006
|
| 14 |
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1037945
|
| 15 |
Alessandra Caligiuri, Mirella Pastore, Giulia Lori, Chiara Raggi, Giovanni Di Maira, Fabio Marra, Alessandra Gentilini. Role of Chemokines in the Biology of Cholangiocarcinoma. Cancers 2020; 12(8) doi: 10.3390/cancers12082215
|
| 16 |
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle, Gregory J. Gores. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2020; 17(9) doi: 10.1038/s41575-020-0310-z
|
| 17 |
Luca Fabris, Keisaku Sato, Gianfranco Alpini, Mario Strazzabosco. The Tumor Microenvironment in Cholangiocarcinoma Progression. Hepatology 2021; 73(S1) doi: 10.1002/hep.31410
|
| 18 |
Tiantian Liu, Hao Wu, Jianni Qi, Chengyong Qin, Qiang Zhu. Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma. Cancer Medicine 2020; 9(20) doi: 10.1002/cam4.3406
|
| 19 |
Anja Moncsek, Joachim C. Mertens. Diagnosis and Management of Cholangiocarcinoma. 2021; doi: 10.1007/978-3-030-70936-5_24
|
| 20 |
YaLan Hu, Kui Wang, Yuhua Chen, Yongli Jin, Qiang Guo, Hui Tang. Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1430551
|
| 21 |
Chao Liu, Mingjie Li, Lichao Liu, Qian Xu, Linlin Zheng, Cailing Wu, Jinghua Ren, Tao Zhang, Haihong Wang, Zhenyu Lin. TGF-β1 induces autophagy and mediates the effect on macrophages differentiation in primary liver cancer. International Immunopharmacology 2025; 157 doi: 10.1016/j.intimp.2025.114799
|
| 22 |
Chao Yin, Ali Alqhatani, Aiwu Ruth He. Cancer Treatment. Handbook of Cancer and Immunology 2025; 7 doi: 10.1007/978-3-032-00769-8_222
|
| 23 |
Evgeny V. Denisov, Tatiana S. Gerashchenko, Marina V. Zavyalova, Vasiliy N. Manskikh, Evgeny L. Choinzonov, Nadezhda V. Cherdyntseva, Vladimir M. Perelmuter. Hepatocellular Carcinoma. 2016; doi: 10.1007/978-3-319-34214-6_14
|
| 24 |
Siqi Yang, Ruiqi Zou, Yushi Dai, Yafei Hu, Fuyu Li, Haijie Hu. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review). International Journal of Oncology 2023; 63(6) doi: 10.3892/ijo.2023.5585
|
| 25 |
Romain Donne, Amaia Lujambio. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 2023; 77(5) doi: 10.1002/hep.32740
|
| 26 |
Chunhong Zheng, Liangtao Zheng, Jae-Kwang Yoo, Huahu Guo, Yuanyuan Zhang, Xinyi Guo, Boxi Kang, Ruozhen Hu, Julie Y. Huang, Qiming Zhang, Zhouzerui Liu, Minghui Dong, Xueda Hu, Wenjun Ouyang, Jirun Peng, Zemin Zhang. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 2017; 169(7) doi: 10.1016/j.cell.2017.05.035
|
| 27 |
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.005
|
| 28 |
Xuan Li, Yan Wang, Renchu Guan, Nan Sheng, Shuangquan Zhang. Multi-Omics Profiling Unveils the Complexity and Dynamics of Immune Infiltrates in Intrahepatic Cholangiocarcinoma. Biology 2024; 13(10) doi: 10.3390/biology13100816
|
| 29 |
Katsuki Miyazaki, Yuji Morine, Shinichiro Yamada, Yu Saito, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita, Takeshi Oya, Tetsuya Ikemoto, Satoru Imura, Haun Hu, Hisayoshi Morioka, Koichi Tsuneyama, Mitsuo Shimada. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient. International Journal of Clinical Oncology 2021; 26(12) doi: 10.1007/s10147-021-02026-3
|
| 30 |
Hang Yuan, Jiaxi Mao, Cong Liu, Hong Fu, Wenyuan Guo, Guoshan Ding. Risk of adverse events in advanced hepatocellular carcinoma with immune checkpoint therapy: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6) doi: 10.1016/j.clinre.2020.02.012
|
| 31 |
Chunye Zhang, Ming Yang, Aaron C. Ericsson. Antimicrobial Peptides: Potential Application in Liver Cancer. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01257
|
| 32 |
Bridget P. Keenan, Lawrence Fong, Robin K. Kelley. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0749-z
|
| 33 |
Yan Shao, Chung Mau Lo, Chang Chun Ling, Xiao Bing Liu, Kevin Tak-Pan Ng, Andrew Chi Yuen Chu, Yuen Yuen Ma, Chang Xian Li, Sheung Tat Fan, Kwan Man. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway. Cancer Letters 2014; 355(2) doi: 10.1016/j.canlet.2014.09.026
|
| 34 |
Nicholas J. W. Easom, Michael Marks, Dawda Jobe, Roopinder Gillmore, Tim Meyer, Mala K. Maini, Ramou Njie. ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00971
|
| 35 |
Yan Zhou, Qian Gu, Linxi Zhu, Shuo Zhang, Hongyan Wu, Xiaohong Pu, Chunping Jiang, Jun Chen. High endothelial venule is a prognostic immune‐related biomarker in patients with resected intrahepatic cholangiocarcinoma. Cell Proliferation 2023; 56(12) doi: 10.1111/cpr.13513
|
| 36 |
Xinyi Huang, Shuang Zheng, Shuqi Li, Yu Huang, Wenhui Zhang, Fang Liu, Qinghua Cao. Machine Learning–Based Pathomics Model Predicts Angiopoietin-2 Expression and Prognosis in Hepatocellular Carcinoma. The American Journal of Pathology 2025; 195(3) doi: 10.1016/j.ajpath.2024.12.005
|
| 37 |
Emilien Loeuillard, Caitlin B. Conboy, Gregory J. Gores, Sumera I. Ilyas. Immunobiology of cholangiocarcinoma. JHEP Reports 2019; 1(4) doi: 10.1016/j.jhepr.2019.06.003
|
| 38 |
Swetha Kambhampati Thiruvengadam, Kelly E. Bauer, Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, John D. Gordan, Robin K. Kelley. Nivolumab in patients with advanced hepatocellular carcinoma and Child‐Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer 2019; 125(18) doi: 10.1002/cncr.32206
|
| 39 |
Ilenia Bartolini, Matteo Risaliti, Rosaria Tucci, Paolo Muiesan, Maria Novella Ringressi, Antonio Taddei, Amedeo Amedei. Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment. World Journal of Gastrointestinal Oncology 2021; 13(11): 1616-1631 doi: 10.4251/wjgo.v13.i11.1616
|
| 40 |
Ines Malenica, Matteo Donadon, Ana Lleo. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine. Cancers 2020; 12(8) doi: 10.3390/cancers12082190
|
| 41 |
Olga Salnikova, Kai Breuhahn, Natalie Hartmann, Jan Schmidt, Eduard Ryschich. Endothelial plasticity governs the site‐specific leukocyte recruitment in hepatocellular cancer. International Journal of Cancer 2013; 133(10) doi: 10.1002/ijc.28268
|
| 42 |
Chao Yin, Ali Alqhatani, Aiwu Ruth He. Handbook of Cancer and Immunology. 2022; doi: 10.1007/978-3-030-80962-1_222-1
|
| 43 |
Luca Vigano, Cristiana Soldani, Barbara Franceschini, Matteo Cimino, Ana Lleo, Matteo Donadon, Massimo Roncalli, Alessio Aghemo, Luca Di Tommaso, Guido Torzilli. Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery. Journal of Gastrointestinal Surgery 2019; 23(11) doi: 10.1007/s11605-019-04111-5
|
| 44 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174154
|
| 45 |
Taek Chung, Hyungjin Rhee, Hyo Sup Shim, Jeong Eun Yoo, Gi Hong Choi, Haeryoung Kim, Young Nyun Park. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut and Liver 2022; 16(4) doi: 10.5009/gnl210174
|
| 46 |
Taiyu Shi, Donghao Cheng, Xinyan Du, Jianning Wang, Siyuan Jiang, Liangyu Yang, Fen Chen, Chenxu Gong, Yan Ou, Bangjie Chen, Yiwen Jia, Songyun Zhao. Exploration of the Roles and Mechanisms Between Tumor‐Infiltrating Lymphocytes and Hepatocellular Carcinoma Based on Single‐Cell Transcriptomics. International Journal of Genomics 2025; 2025(1) doi: 10.1155/ijog/1575734
|
| 47 |
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Hepatocellular Carcinoma and the Multifaceted Relationship with Its Microenvironment: Attacking the Hepatocellular Carcinoma Defensive Fortress. Cancers 2024; 16(10) doi: 10.3390/cancers16101837
|
| 48 |
Mingzhen Zhou, Ziyan Zhou, Lina Hu, Sidong Chen, Fanyan Meng, Jun Chen, Jie Shen. Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06106-0
|
| 49 |
Monika Vyas, Dhanpat Jain. An update on subtypes of hepatocellular carcinoma: From morphology to molecular. Indian Journal of Pathology and Microbiology 2021; 64(5) doi: 10.4103/IJPM.IJPM_751_20
|
| 50 |
S. Ohfuji. Hepatocellular carcinoma in a cow: detection of tumor-infiltrating T lymphocytes implicated in anti-tumor immune response and partial spontaneous tumor regression. Comparative Clinical Pathology 2016; 25(2) doi: 10.1007/s00580-015-2202-0
|
| 51 |
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Critical Reviews in Oncology/Hematology 2015; 94(3) doi: 10.1016/j.critrevonc.2015.01.009
|
| 52 |
Jin-Guo Liu, Lin Yu, Xian-Ling Guo, Xue-Min He, Man Li, Ren-Yuan Gao, Bing-Hui Zhao, Qian-Yu Li, Wen-Jing Zhu, Ping Xu, Xiao-Hua Gu, Yong-An Chen, Xiao-Lan Yin, Yan Shang, Zhen-Hong Guo, Jia-Hao Mao, Yang-Xi Hu, Li-Ming Lu, Jian Hua, Hua Zhang, Yue Li. Characterizing the immune landscape of tumor-infiltrating lymphocytes in non-small cell lung cancer. Genes & Immunity 2025; 26(3) doi: 10.1038/s41435-025-00330-w
|
| 53 |
Tingting Fang, Li Feng, Jinglin Xia. Application of Clinical Bioinformatics. Translational Bioinformatics 2016; 11 doi: 10.1007/978-94-017-7543-4_16
|
| 54 |
Florian Haag, Anjana Manikkam, Daniel Kraft, Caroline Bär, Vanessa Wilke, Aleksander J. Nowak, Jessica Bertrand, Jazan Omari, Maciej Pech, Severin Gylstorff, Borna Relja. Selective Internal Radiotherapy Changes the Immune Profiles of Extracellular Vesicles and Their Immune Origin in Patients with Inoperable Cholangiocarcinoma. Cells 2022; 11(15) doi: 10.3390/cells11152309
|
| 55 |
Amedeo Sciarra, Inês Monteiro, Christine Ménétrier-Caux, Christophe Caux, Benoit Gilbert, Nermin Halkic, Stefano La Rosa, Pedro Romero, Christine Sempoux, Laurence de Leval. CD73 expression in normal and pathological human hepatobiliopancreatic tissues. Cancer Immunology, Immunotherapy 2019; 68(3) doi: 10.1007/s00262-018-2290-1
|
| 56 |
Giovanni Vitale, Stefano Gitto, Claudia Campani, Laura Turco, Anna Baldan, Fabio Marra, Maria Cristina Morelli. Biological therapies in patients with liver disease: are they really lifesavers?. Expert Opinion on Biological Therapy 2022; 22(4) doi: 10.1080/14712598.2022.2013799
|
| 57 |
Luca Fabris, María J. Perugorria, Joachim Mertens, Niklas K. Björkström, Thorsten Cramer, Ana Lleo, Antonio Solinas, Hanna Sänger, Veronika Lukacs‐Kornek, Anja Moncsek, Alexander Siebenhüner, Mario Strazzabosco. The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International 2019; 39(S1) doi: 10.1111/liv.14098
|
| 58 |
Taek Chung, Young Nyun Park. Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.857140
|
| 59 |
Miaomiao Qin, Danping Wang, Yijiao Fang, Zhiying Zheng, Xinyang Liu, Fan Wu, Liangliang Wang, Xiao Li, Bingqing Hui, Shijie Ma, Weiwei Tang, Xiongxiong Pan. Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.647854
|
| 60 |
Lorenza Rimassa, Nicola Personeni, Alessio Aghemo, Ana Lleo. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine. Journal of Autoimmunity 2019; 100 doi: 10.1016/j.jaut.2019.03.007
|
| 61 |
Giulia Milardi, Ana Lleo. Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment. Cancers 2023; 15(7) doi: 10.3390/cancers15072182
|
| 62 |
Yunyan Dai, Chenyang Dong, Zhiming Wang, Yunpeng Zhou, Yi Wang, Yi Hao, Pinggui Chen, Chaojie Liang, Gaopeng Li. Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1482291
|
| 63 |
Dong Liu, Lara Rosaline Heij, Zoltan Czigany, Edgar Dahl, Sven Arke Lang, Tom Florian Ulmer, Tom Luedde, Ulf Peter Neumann, Jan Bednarsch. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02340-2
|
| 64 |
Zi-jian Zhang, Yun-peng Huang, Zhong-tao Liu, Yong-xiang Wang, Hui Zhou, Ke-xiong Hou, Ji-wang Tang, Li Xiong, Yu Wen, Sheng-fu Huang. Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1028404
|
| 65 |
Maria‐Danae Jessel, Owen McGreevy, Lauryn McReynolds, Lekh N Dahal, Timothy Gilbert, Hassan Z Malik, Christopher E Goldring, Laura E Randle. Targeting the tumor microenvironment in cholangiocarcinoma to improve immune checkpoint blockade: potential strategies and translational pre‐clinical models. Clinical & Translational Immunology 2025; 14(10) doi: 10.1002/cti2.70057
|
| 66 |
Zhenyun Yang, Deyao Zhang, Huilan Zeng, Yizhen Fu, Zili Hu, Yangxun Pan, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Dandan Hu, Minshan Chen. Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. Journal of Inflammation Research 2022; doi: 10.2147/JIR.S385921
|
| 67 |
Xingyuan Xu, Longyun Ye, Qi Zhang, Hang Shen, Shanshan Li, Xiaoyu Zhang, Mao Ye, Tingbo Liang. Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression. Hepatology 2021; 74(5) doi: 10.1002/hep.31855
|
| 68 |
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos, Flora Zagouri. The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines 2021; 9(5) doi: 10.3390/vaccines9050422
|
| 69 |
Nikolaos Charalampakis, Georgios Papageorgiou, Sergios Tsakatikas, Rodanthi Fioretzaki, Christo Kole, Stylianos Kykalos, Maria Tolia, Dimitrios Schizas. Immunotherapy for Cholangiocarcinoma: a 2021 Update. Immunotherapy 2021; 13(13) doi: 10.2217/imt-2021-0126
|
| 70 |
Ai-Yu Nie, Zhong-Hui Xiao, Jia-Li Deng, Na Li, Li-Yuan Hao, Sheng-Hao Li, Xiao-Yu Hu. Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(2): 98556 doi: 10.4251/wjgo.v17.i2.98556
|
| 71 |
Lara Heij, Sikander Hayat, Konrad Reichel, Sidrah Maryam, Colm J. O’Rourke, Xiuxiang Tan, Marlous van den Braber, Jan Verhoeff, Maurice Halder, Fabian Peisker, Georg Wiltberger, Jan Bednarsch, Daniel Heise, Julia Campello Deierl, Sven A. Lang, Florian Ulmer, Tom Luedde, Edgar Dahl, Danny Jonigk, Jochen Nolting, Shivan Sivakumar, Jens Siveke, Florian Vondran, Flavio G. Rocha, Hideo A. Baba, Sylvia Hartmann, Jesper B. Andersen, Zaynab Hobloss, Ahmed Ghallab, Jan G. Hengstler, Juan J. Garcia Vallejo, Rafael Kramann, Ulf Neumann. Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients. npj Precision Oncology 2026; 10(1) doi: 10.1038/s41698-026-01292-6
|
| 72 |
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, Andrew X. Zhu. Systemic therapies for intrahepatic cholangiocarcinoma. Journal of Hepatology 2020; 72(2) doi: 10.1016/j.jhep.2019.10.009
|